What is Idoven?
Idoven operates as a sophisticated cardiology-as-a-service platform, leveraging artificial intelligence to analyze electrocardiogram data with unprecedented speed and accuracy. By automating the interpretation of complex cardiac signals, the company provides clinicians with actionable insights, effectively reducing diagnostic bottlenecks. Positioned at the intersection of health-tech and deep-learning, Idoven is scaling its operations to address the global burden of cardiovascular disease, a market segment increasingly prioritized by enterprise-level healthcare providers and digital health innovators.
How much funding has Idoven raised?
Idoven has raised a total of $19.8M across 2 funding rounds:
Grant
$6.9M
Series A
$12.9M
Grant (2022): $6.9M with participation from European Innovation Council (EIC) Accelerator
Series A (2022): $12.9M led by Wayra, Insight Partners, and Northzone
Key Investors in Idoven
Insight Partners
A global venture capital and private equity firm that invests in high-growth technology and software companies, providing deep operational support to scale businesses.
Northzone
A prominent early-stage venture capital firm with a focus on European technology companies, known for supporting disruptive digital health and software ventures.
Wayra
The open innovation hub of Telefonica, specializing in connecting startups with corporate resources to accelerate growth and technological adoption.
What's next for Idoven?
Following this major enterprise-level funding, Idoven is well-positioned to transition from its current scaling phase into broader international market penetration. The strategic deployment of this capital will likely focus on enhancing the platform's diagnostic capabilities, expanding clinical validation studies, and strengthening its regulatory footprint across European and global markets. As the company matures, the focus will shift toward deepening integration with existing hospital infrastructure and refining its AI models to support a wider array of cardiac conditions, ensuring long-term sustainability and competitive advantage in the rapidly evolving digital cardiology landscape.
See full Idoven company page
